ProfileGDS5678 / 1434503_s_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 111.162899
GSM967853U87-EV human glioblastoma xenograft - Control 211.430599
GSM967854U87-EV human glioblastoma xenograft - Control 311.244899
GSM967855U87-EV human glioblastoma xenograft - Control 410.982599
GSM967856U87-EV human glioblastoma xenograft - Control 511.074199
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 110.895699
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 210.66299
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 311.00799
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 410.955699
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 110.928899
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 210.801499
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 310.929899
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 410.751799
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 510.871699